AKT1 and cancer: Notably, the significantly enriched KEGG pathways included Pathways in cancer, EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, Prostate cancer, Proteoglycans in cancer, Endocrine resistance, Ras signaling pathway, Pancreatic cancer, Fc epsilon RI signaling pathway, and Hepatitis B (Figure 4).